Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.: Complete Statistical AnalysisIndependent statistical analysis of To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.: Complete Statistical AnalysisIndependent statistical analysis of To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TOBA II BTKIndependent statistical analysis of Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TOBEIndependent statistical analysis of The Digital Breast Tomosynthesis Trial in Bergen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02835625).
- TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: Complete Statistical AnalysisIndependent statistical analysis of TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TOCCATAIndependent statistical analysis of TOCCATA - Touch+™ for Catheter Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01223469).
- Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tocilizumab for Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01450137).
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TOCPIndependent statistical analysis of Tailoring Online Continence Promotion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05183217).
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib for the Treatment of Alopecia Areata and Its Variants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312882).
- Tofacitinib Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831466).
- TOFUIndependent statistical analysis of A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TOGETHERIndependent statistical analysis of Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment: primary endpoint results, effect estimate with…
- Tolcapone in Obsessive Compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Tolcapone in Obsessive Compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03348930).
- Tolcapone Treatment of Pathological Gambling: Complete Statistical AnalysisIndependent statistical analysis of Tolcapone Treatment of Pathological Gambling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00927563).
- Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age: Complete Statistical AnalysisIndependent statistical analysis of Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study): Complete Statistical AnalysisIndependent statistical analysis of Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study): primary endpoint results,…
- Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00753987).
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): Complete Statistical AnalysisIndependent statistical analysis of Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolvaptan for Ascites in Cirrhotic Patients: Complete Statistical AnalysisIndependent statistical analysis of Tolvaptan for Ascites in Cirrhotic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01292304).
- TOMOIndependent statistical analysis of Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TONICIndependent statistical analysis of Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00063635).
- TOPIndependent statistical analysis of A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TOPIndependent statistical analysis of Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOP1201 IPIIndependent statistical analysis of Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence…
- TOPASIndependent statistical analysis of Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZIndependent statistical analysis of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.: primary endpoint results, effect estimate with confidence interval, sample-size…
- TOPAZIndependent statistical analysis of An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZ-1Independent statistical analysis of Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZ-IIndependent statistical analysis of A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV)…
- Topera C-FIRM Registry: Complete Statistical AnalysisIndependent statistical analysis of Topera C-FIRM Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02407249).
- Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02664909).
- Topical Anesthetic Use In Pessary Management: Complete Statistical AnalysisIndependent statistical analysis of Topical Anesthetic Use In Pessary Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02380742).
- Topical Antibiotics and Intravitreous Injections: Complete Statistical AnalysisIndependent statistical analysis of Topical Antibiotics and Intravitreous Injections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00410891).
- Topical Antimicrobial Effectiveness Testing: Complete Statistical AnalysisIndependent statistical analysis of Topical Antimicrobial Effectiveness Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314703).
- Topical Avastin for Treatment of Corneal Neovascularization: Complete Statistical AnalysisIndependent statistical analysis of Topical Avastin for Treatment of Corneal Neovascularization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00559936).
- Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855607).
- Topical NVN1000 for the Treatment of External Genital and Perianal Warts: Complete Statistical AnalysisIndependent statistical analysis of Topical NVN1000 for the Treatment of External Genital and Perianal Warts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Topical Radial Artery Vasodilation: Complete Statistical AnalysisIndependent statistical analysis of Topical Radial Artery Vasodilation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01155167).
- Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC): Complete Statistical AnalysisIndependent statistical analysis of Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Topical Ruxolitinib Evaluation in Chronic Hand Eczema: Complete Statistical AnalysisIndependent statistical analysis of Topical Ruxolitinib Evaluation in Chronic Hand Eczema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05906628).
- Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD): Complete Statistical AnalysisIndependent statistical analysis of Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395340).
- Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face: Complete Statistical AnalysisIndependent statistical analysis of Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Topical Tranexamic Acid (TXA) in Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Topical Tranexamic Acid (TXA) in Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01937559).
- Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Topical Treatment and Prevalence of P. Acnes: Complete Statistical AnalysisIndependent statistical analysis of Topical Treatment and Prevalence of P. Acnes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257202).